Amoxicillin Derivative for Treatment of Lyme Disease
ISEF · 2015 Energy: Sustainable Materials and Design
Overview
Ever since it’s discovery in 1975, Lyme Disease has been an issue especially in North America and effects both children and adults. In 2013, the Center for Disease Control and Prevention (CDC) has reported more than 27,203 cases in just the U.S alone. This vector borne disease is caused by the bacterium Borrelia Burgdorferi, a spirochete, which is a phylogenetically-distinct bacteria. The outer membrane of Borrelia Burgdorferi is composed of various unique outer surface proteins (Osp) that have been characterized (Osp A through OspF). Although this bacterium is extracellular, its interaction with the extracellular matrix allows the blood to be released to the surrounding tissues which initiates the infection. The fact that there is a wide genetic variability of the different strands of the bacterium as well as it’s ability to mimics other common diseases, makes Lyme disease very hard to detect. Currently, the most efficient drug available to treat Lyme disease is Amoxicillin. This prescribed antibiotic similar to penicillin does not completely eradicate the bacteria, but reduces the rate at which the bacteria multiplies. Through computational analysis, manipulation of the structure of Amoxicillin showed improved binding affinity to better control the multiplicity of Borrelia Burgdorferi and possibly disintegrate the bacterium completely. The main objective of this project is to develop an efficient five step synthetic route for the proposed derivative of Amoxicillin. Various spectroscopic analysis, Thin Layer Chromatography (TLC), Mass Spectrometer, Infrared Spectroscopy (IR) and Nuclear Magnetic Resonance (NMR), will be used to determine the reaction times and purity of each intermediate compound as well as the final synthesized Amoxicillin derivative.
Competition history
- ISEF 2015
Resources
Related projects
ISEF · 2018
Detecting the Elusive Lyme Disease, Year Two: Creating a Novel Diagnostic Aid for the Detection of Borrelia burgdorferi in Ticks
ISEF · 2017
Detecting the Elusive Lyme Disease: Creating a Novel Lateral Flow Test for Detection of Borrelia burgdorferi in Ticks
ISEF · 2017
Development of an Antigen-Detection Diagnostic Assay for Lyme Disease
ISEF · 2020
Towards the Total Synthesis of the Leishmanicidal Lindbergin E for the Development of a Novel Phloroglucinol-Derived Asymmetric Cyclic Polyketide Synthesis
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair